Gamma and Delta Neural Oscillations and Association with Clinical Symptoms under Subanesthetic Ketamine
- 4 November 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neuropsychopharmacology
- Vol. 35 (3), 632-640
- https://doi.org/10.1038/npp.2009.168
Abstract
Several electrical neural oscillatory abnormalities have been associated with schizophrenia, although the underlying mechanisms of these oscillatory problems are unclear. Animal studies suggest that one of the key mechanisms of neural oscillations is through glutamatergic regulation; therefore, neural oscillations may provide a valuable animal-clinical interface on studying glutamatergic dysfunction in schizophrenia. To identify glutamatergic control of neural oscillation relevant to human subjects, we studied the effects of ketamine, an N-methyl-D-aspartate antagonist that can mimic some clinical aspects of schizophrenia, on auditory-evoked neural oscillations using a paired-click paradigm. This was a double-blind, placebo-controlled, crossover study of ketamine vs saline infusion on 10 healthy subjects. Clinically, infusion of ketamine in subanesthetic dose significantly increased thought disorder, withdrawal-retardation, and dissociative symptoms. Ketamine significantly augmented high-frequency oscillations (gamma band at 40-85 Hz, p=0.006) and reduced low-frequency oscillations (delta band at 1-5 Hz, p<0.001) compared with placebo. Importantly, the combined effect of increased gamma and reduced delta frequency oscillations was significantly associated with more withdrawal-retardation symptoms experienced during ketamine administration (p=0.02). Ketamine also reduced gating of the theta-alpha (5-12 Hz) range oscillation, an effect that mimics previously described deficits in schizophrenia patients and their first-degree relatives. In conclusion, acute ketamine appeared to mimic some aspects of neural oscillatory deficits in schizophrenia, and showed an opposite effect on scalp-recorded gamma vs low-frequency oscillations. These electrical oscillatory indexes of subanesthetic ketamine can be potentially used to cross-examine glutamatergic pharmacological effects in translational animal and human studies.This publication has 101 references indexed in Scilit:
- Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentialsNeurobiology of Disease, 2009
- Sensory Gating Endophenotype Based on Its Neural Oscillatory Pattern and Heritability EstimateArchives of General Psychiatry, 2008
- Prolonged Exposure to NMDAR Antagonist Suppresses Inhibitory Synaptic Transmission in Prefrontal CortexJournal of Neurophysiology, 2008
- GABA Neurons and the Mechanisms of Network Oscillations: Implications for Understanding Cortical Dysfunction in SchizophreniaSchizophrenia Bulletin, 2008
- Region-Specific Changes in Gamma and Beta2 Rhythms in NMDA Receptor Dysfunction Models of SchizophreniaSchizophrenia Bulletin, 2008
- Loss of the innate immunity negative regulator IRAK-M leads to enhanced host immune defense against tumor growthMolecular Immunology, 2007
- Differential regulation and role of interleukin-1 receptor associated kinase-M in innate immunity signalingCellular Signalling, 2007
- Impairments in frontal cortical γ synchrony and cognitive control in schizophreniaProceedings of the National Academy of Sciences of the United States of America, 2006
- Failure to Find P50 Suppression Deficits in Young First-Episode Patients With Schizophrenia and Clinically Unaffected SiblingsSchizophrenia Bulletin, 2006
- Sepsis-induced suppression of lung innate immunity is mediated by IRAK-MJCI Insight, 2006